Skip to content

Evaluating the practicality of the ‘My Medicines Journey’ intervention for older people living with frailty and other long-term conditions

Assessing the feasibility and implementation of the 'My Medicines Journey' intervention: a multi-methods evaluation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10902495
Enrollment
168
Registered
2025-01-21
Start date
2025-04-10
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ageing Other

Interventions

This is a mixed-method feasibility study of a co-designed intervention called the ‘My Medicines Journey’ toolkit. The aim is to support older people in better managing their medicines after hospital d

Sponsors

Bradford Teaching Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Aged 75 years plus 2. Living with frailty (based on clinical judgement) 3. Living with one or more long-term condition(s) 4. Using five or more regular medicines 5. Returning to a domiciliary setting 6. At least one medicine change during inpatient stay 7. Manage medicines without a formal social care package, i.e., the patient does not rely on formal paid carers for the administration of medicines

Exclusion criteria

Exclusion criteria: 1. Are on the End-of-Life pathway 2. Are discharged to a temporary care setting 3. Reside in a care home 4. Medicines are administered by formal paid care providers 5. Lack capacity (assessed by the care team and/or research nurse)

Design outcomes

Primary

MeasureTime frame
1.Rate of recruitment measured using Median Recruitment Rate (MRR) at months 1, 2, 3, 4, 5, and 6 of the overall recruitment period 2.Loss of follow-up at 2 months measured using the Percentage Method at 2 months post-discharge 3.Intervention delivery measured using observations and interviews at months 19, 20, 21, 22, 23 and 24 of the overall study period 4.Participation engagement with the intervention measured using routine data, observations, questionnaires and interviews at months 19, 20, 21, 22, 23 and 24 of the overall study period 5.Evidence of feasibility of collecting outcome measures measured using PREM questionnaires, EQ5D questionnaire, healthcare utilisation questionnaire, MARS_5 scale, SEAMS scale and MRP questionnaire at 2 weeks post-discharge and 3 months post-discharge

Secondary

MeasureTime frame
1. [PREM] measured using a questionnaire [2 weeks post-discharge and 3 months post-discharge]. 2. [Quality of Life] measured using the EQ5D questionnaire [2 weeks post-discharge and 3 months post-discharge] 3. [Healthcare utilisation] measured using a healthcare utilisation questionnaire [2 weeks post-discharge and 3 months post-discharge] 4. [Adherence] measured using a MARS_5 scale [2 weeks post-discharge and 3 months post-discharge] 5. [Self-efficacy] measured using the SEAMS scale [2 weeks post-discharge and 3 months post-discharge] 6. [Medicines-related problems (MRPs)] measured using an MRP questionnaire [2 weeks post-discharge and 3 months post-discharge]

Countries

England, United Kingdom

Contacts

Public ContactAdam Nyende
adam.nyende@bthft.nhs.uk+44 (0) 7442344460

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026